# Shanghai Polaris Biology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-polaris-biology-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.polarisbiology.com
- Total disclosed funding: $18M
- Latest round: Series B (Jun 24, 2020)
- Investors on record: 9

## About

Established in 2016 and based in Shanghai, China, Shanghai Polaris Biology Co., Ltd. operates as a cancer treatment service provider which develops diagnosis and treatment of tumors through cell level study and individual differences and changes in tumors.

## Funding rounds

- Series B, Jun 24, 2020, $9.9M — 5Y Capital, Baidu Ventures, Delian Capital, Volcanics Venture, Jinkong Qiyuan Capital, Daokang Zhihe, Ascendin Fund
- Series A, Sep 5, 2019 — Baidu Ventures
- Series A, Jan 19, 2019, $8.3M — 5Y Capital, Volcanics Venture, Daokang Zhihe
- Angel, Mar 12, 2018 — Puhua Capital
- Seed, May 3, 2016 — Dalton Venture

## Investors

- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Seed
- Puhua Capital (https://capitalatlas.ai/funds/puhua-capital) — Angel
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A, Series B
- Volcanics Venture (https://capitalatlas.ai/funds/volcanics-venture) — Series A, Series B
- Daokang Zhihe — Series A, Series B
- Baidu Ventures (https://capitalatlas.ai/funds/baidu-ventures) — Series A, Series B
- Delian Capital (https://capitalatlas.ai/funds/delian-capital) — Series B
- Jinkong Qiyuan Capital (https://capitalatlas.ai/funds/jinkong-qiyuan-capital) — Series B
- Ascendin Fund (https://capitalatlas.ai/funds/ascendin-fund) — Series B